Number of Current Board & Advisor Roles 10
CB Rank (Investor) 157,888
  • Investor Type  Investment Partner

Dr. Arnie Oronsky has been with InterWest's life sciences team since 1994.

He is a board member of Amplimmune, Applied Genetic Technologies Corporation (AGTC), Arcion, Drais Pharmaceuticals, Dynavax Technologies (DVAX), Integrated Diagnostics, MacroGenics, RadioRX, TESARO and USDS.

As a Ph.D. in immunology and senior lecturer at the

Department of Medicine at Johns Hopkins Medical School, Arnie brings a deep understanding of medical research to finding and investing in successful life sciences companies.

Prior to joining InterWest, Arnie was vice president for discovery research of the Lederle Laboratories division of American Cyanamid Company where he directed the research for new drugs.

Arnie received a Ph.D. in immunology from Columbia University and has published more than 125 articles in scientific journals.

Number of Current Jobs 2
Number of Past Jobs 1
Arnie Oronsky has 2 current jobs as Managing Director at InterWest Partners and Senior Lecturer at the Department of Medicine at Johns Hopkins University School of Medicine. Additionally, Arnie Oronsky has had 1 past job as the Vice President for Discovery Research of the Lederle Laboratories Division at American Cyanamid Company.
Organization Name  
Title At Company  
Start Date  
End Date  
American Cyanamid Company
Vice President for Discovery Research of the Lederle Laboratories Division
Number of Current Board & Advisor Roles 10
Number of Past Board & Advisor Roles 1
Arnie Oronsky holds 10 board and advisor roles including Board of Directors at Dynavax Technologies, Board of Directors at Integrated Diagnostics, and Board Member at Arcion Therapeutics.
Organization Name  
Title At Company  
Start Date  
End Date  
USDS
Board Member
There is no recent news or activity for this profile.